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Summary: The reliability of lysozyme (EC. 3.2.1.17) activity estimations with the lysoplate assay method of
Osserman &Lawlor ((1966), J. Exp. Med. 124, 921—952) in the feces of infants was investigated. It was found
that the precision of the method is relatively high, despite the influence of inhibitors present in material investigated.
The activity of lysozyme in feces was estimated in a control group of 50 healthy infants and in a group of 152
infants with acute diarrhoea. All infants investigated were artificially nourished. In the latter group the activity of
lysozyme was estimated twice: a) at the beginning of clinically active phase of the disease and b) in the convalescence
period immediately after withdrawal of clinical symptoms.
The range of normal values was 14.9—77.0 (average 44.0) of egg-white lysozyme units/g dry feces. In acute diarrhoea
the activity of lysozyme in feces was found to be elevated in 72.4% of cases in the first determination and in an
additional 7.6% of cases in the second determination (i.e. a total of 80% of cases in both determinations). The
average elevations of lysozyme activity in the feces and the dynamics of their normalization after withdrawal of
clinical symptoms were generally related to the severity of the disease.
Diagnostische Bedeutung der Bestimmung von Lysozym in Faeces bei Kindern mit akuter Diarrhöe
Zusammenfassung: Die Zuverlässigkeit der Bestimmung von Lysozym (EC. 3.2.1.17) mit dem „lyso-plate-assay" von
Osserman & Lawlor ((1966), J. Exp. Med. 124, 921—952) in Faeces von Kindern wurde untersucht. Ungeachtet des
Einflusses von Inhibitoren im Untersuchungsmaterial wurde festgestellt, daß die Präzision der Methode relativ hoch
ist.
Lysozym wurde in Faeces von 50 gesunden Kindern (Kontrollgruppe) und 152 Kindern mit akuter Diarrhöe bestimmt.
Alle Kinder wurden mit künstlicher Nahrung ernährt. In der Gruppe der kranken Kinder wurde Lysozym a) zu Be-
ginn der klinisch aktiven Phase der Erkrankung und b) in der Gesundungsphase unmittelbar nach Verschwinden der
klinischen Symptome bestimmt.
Der Normalbereich lag bei 14,9—77,0 (x = 44,0) Eiklar-Lysozym-Einheiten/g Trpckenfaeces. Bei akuter Diarrhöe
war Lysozym in 72,4% der Fälle bei der ersten und in zusätzlich 7,6% der Fälle bei der zweiten Bestimmung (ins-
gesamt also 80% äer Fälle) erhöht. Die erhöhten Werte für Lysozym in Faeces und der Verlauf der Normalisierung
und Verschwinden der klinischen Symptome waren generell mit der Schwere der Erkrankung korreliert.
Introduction
Acute diarrhoea in infants is considered today äs a
general pathological condition in which the most
characteristic feature is the elimination of untolerable
substances of endogenic and/or exogenic origin (1—4).
Usually the attention of pathologists is directed towards
the disturbances affecting the whole organism (2—7)
and the local pathological changes of the intestinal wall
are often neglected (1, 2? 4, 6, 7), despite their im-
portance in the development and progress of the disease.
The typical, basic local pathological changes in small
intestine in acute diarrhoea of infants can be morpho-
logically characterized as enlargement of intestinal
capillaries (8—10) and inflammatory infiltrations with
typical, cellular components, such as plasmatic cells,
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lymphocytes (11-15), neutrophilic (11, 15-19)
granulocytes, monocytes and macrophages (20—22) of
which the three last are known to be rich in lysozyme
(23, 24).
Our previous observations (25) as well as those of other
authors (26) suggest that it should be possible to
evaluate indirectly the morphotic state of intestinal
mucosa by the estimation of lysozyme activity in the
feces.
According to Braun (27-29) and Haneberg & Finne
(30) there is no or very little lysozyme activity in the
feces of healthy artificially nourished infants. (In nursed
infants the lysozyme activity in the feces derives mainly
from mother milk). This activity may be increased in
acute diarrhoea (27, 28, 29).
On the basis of the observations ofSenn et al. (24) it
was possible to conclude that in inflammatory infiltrated
intestinal mucosa the amount of lysozyme may increase
in parallel with the immigration of neutrophilic granulo-
cytes, monocytes and macrophages. It seemed likely
that lysozyme would be liberated into intestinal fluid
from the above mentioned cellular elements as a result
of its increased production within these cells (23, 31-33)
or as a result of the destruction of the cells.
Taking this in account it was of interest to investigate the
potential, diagnostic value of lysozyme estimations in
the feces of infants with acute diarrhoea.
Methods and Materials
Our investigations were performed using the lysoplate diffusion
method of Osserman & Lawlor (34). The activity of lysozyme
was estimated in the extracts of feces samples, dried at 37 °C in
order to eliminate the influence of varying amounts of water
in diarrhoic feces. Lysozyme was extracted from l g of dried
feces with 20 ml of 0.067 mol/1 sodium phosphate buffer,
pH 6.3, containing acetone (5 ml/1 of buffer).
The results calculated from the diameter of the clearing zone
were expressed in egg white lysozyme units Gug/g of dried feces).
In control experiments the precision of the method under
different experimental conditions was less than 15%. The in-
fluence of interfering substances -present in feces was investigated,
as well as the influence of analytical and extraction procedures
(mean inhibition - 78%). Taking in account the results of these
experiments we can assume the satisfactory information value
of estimations of lysozyme activity in feces of infants, at least
for clinical purposes.
Our clinical investigations were performed on 50 healthy, arti-
ficially nourished infants (control group) and on 152 artificially
nourished infants with acute diarrhoea of different severity.
The infants with diarrhoea were divided in 4 groups according to
the severity of the disease (WHO classification) (2, 7):
48 with "light diarrhoea";
68 with "medium severe diarrhoea";
24 with "severe diarrhoea";
12 with "toxic diarrhoea".
Lysozyme activity in feces extracts was estimated twice: at the
begin of the acute phase of the disease (during the first 1-3
days) and after withdrawal of clinical symptoms.
Because the distributions of results obtained in the control group
and in groups of patients were neither normal nor log-normal,
the statistical significance of their differences were calculated
using the x2-test.
In 5 cases the morphological changes in the intestine were also
investigated on autopsy.
Results and Discussion
The reference values (normals) and reference ranges of
lysozyme activity in feces of healthy infants belonging
to the control group were as follows: mean value:
44 units/g, range: 14.9-77.0 units/g.
The changes of lysozyme activity in feces during 1 week
in artificially nourished infants: healthy and with acute
diarrhoea before and during medical treatment are ·
shown in figure L
It can be seen that (fig. 1) in normal conditions the
changes of lysozyme activity in the feces, if any, are
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Fig. 1. The examples of lysozyme activity changes in feces of artificially nourished infants; a) healthy infant Z. M. b) infant Z. E/with
acute diarrhoea untreated during first 6 days; c) infant J. R. with acute diarrhoea immediatelly treated. Remarks: 1) "0-day" -
the last day before onset of the disease (infants Z. E. and J. R.); 2) "7-day" - the first day of the treatment (infant Ζ. Ε.).
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relatively small, but in some cases of acute untreated
diarrhoea, the activity of fecal lysozyme can be very
high on the first day of the disease, undergoing con-
siderable changes later. In other cases the activity of
lysozyme in the feees increased simultaneously with the
intensity of clinical symptoms, and the highest values
were observed later. The effective treatment of the
disease leads to the permanent decrease of lysozyme
activity in the feces.
The frequency of elevated activities of lysozyme in the
feces of infants with acute diarrhoea at the beginning of
the clinically active phase of the disease was significantly
higher than in the control group: χ2 = 58.89 (XQ.OOOS
v=l i*=l
= 12.1 16). This frequency also showed a significant in-
crease with the severity of the illness: χ2= 78.92
v=4
(Xo.ooos = 19.997). The mean values of lysozyme
n=4'
characterizing each group changed in a similar way
(fig- 2).
A statistically greater frequency of elevated lysozyme
activities in feces was already present in the group of
infants with light diarrhoea: χ2 = 15.17 (XQ.OOOS =
i*=l v=l
12.1 16) and statistically greater than in this last group
it was also found in other groups of infants with medium
severe: X2 = 23.82 (xiooos = ! 9,997),
υ=·\ μ=1
severe: χ2 = 13.18 (xg.ooos - ί2^ 16) md toxic
y=l y=l
diarrhoea: χ2 = 7.45 (χ^01 = 6.635). The differences of
v=l *=!*
frequences of elevated lysozyme activities in feces
between groups of infants with medium severe, severe
and toxic diarrhoea were statistically non-significant,
being lower than the critical value of the x2-test: XO.QS
v=l
= 3.841.
In the convalescence period (according to the WHO-
recommendations: no more than 3 fluid stools or 1
stool with mucus- or blood-admixture per 24 hours)
(2,7)- the frequency of elevated lysozyme activities in
feces were significantly lower than in the clinically
active phase of the disease: χ- ~ 18.33 (Xo.poos = ··
i/=l v=l
12.1 16) but always significantly higher than in the
control group: χ2 = 21.25 (XO.OQOS = 12.1 16). The
v=\ v=l
statistical significance of frequences of elevated results
in separate groups of patients was generally similar to
that found in the clinically active phase of the disease
but with considerably lower values in the χ2 -test (tab. 1).
The mean values for lysozyme activity in separated
groups of patients behaved similarly to the changes of
frequences of the elevated lysozyme activities. In the
acute phase of the "light diarrhoea" the mean activity
of lysozyme in the feces was 121.1 units/g and in the
convalescence period 81.7 units/g. In "medium severe
1000
v>
atο
^
 8
°°•o
'Ξ
| 600
S
a»
1 400
cu
<u
Nl
| 200
η
Healthy
infants
ί
_
-
$$$&
Infants with acute diarrhoea
light
m
9
9
JL
•^ •*
medium
severe
Λ
0
9
•
·*-
t^
.
severe
Ai..1)674a9
1U2)2223.9
3)163^8
4»4715
.
8
ί
.%
*
toxic
* (1285.2)
«4rD 3803.7
llU2) 3790.1
3)1910.4
4)1076J9
0
·-
*
,. .--. .,,_
Fig. 2. Lysozyme activity in feces of 202 artificially nourished
infants: healthy and with acute diarrhoea of different
severity - at the begin of acute phase of the disease.
Dotted line : upper and lower limits of normals.
diarrhoea" the respective values were 246.4 units/g and
148.6 units/g, in "severe diarrhoea" 815.6 units/g and
277.7 units/g and in "toxic diarrhoea" 750.1 units/g
and 292.1 units/g.
Summarizing the results obtained in different groups of
patients we can conclude that in the acute phase of the
disease the relative frequency of cases with elevated
lysozyme activities in the feces increases until the group
of "medium severe diarrhoea". In more severe diarrhoeas,
in which almost all results are elevated, the mean values
of lysozyme activity increase further.
After the disappearance of clinical symptoms of
diarrhoea the normalization of lysozyme activity in
feces is observed. However, the frequency of this
normalization decreases with the severity of the disease
and in "severe diarrhoea" only 1/4 of cases show this
response. This is also shown in the mean values of
lysozyme activity in feces, which are higher, depending on
the severity of the diarrhoea.
In the second estimation, we have also found pathological
elevations of lysozyme activities in the feces of about 1/5
of the infants with "light diarrhoea" and in about half
of the infants with "medium severe diarrhoea", in whom
the first investigation showed an activity of lysozyme
within the reference limits (tab. 1).
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Tab. 1. The classification of infants with acute diarrhoea according to the elevated or normal lysozyme activities in feces at the begin
of acute phase of the disease (1 st estimation) and after withdrawal of clinical symptoms (2nd estimation).
Number of cases with lysozyme activity in feces:
elevated in the 1 st estimation: within normals in the 1 st estimation:
in whom the activity in the 2nd
estimation:
in whom the activity in the 2nd
estimation:
further
in-
creased: decreased:
Acute diarrhoea
light
medium severe
severe
toxic
Total:
Percentage:
Total
number
of
cases
in each
group
45
68
23
9
145
Total
20
56
21
8
105
72,4%
3
9
6
1
19
13,1%
remai-
ning yet
elevated
5
23
10
3
41
28,3%
to the
range of
normal
values
9
21
4
3
37
25,5%
below
the
lower
limit
of
normals
3
3
1
1
8
5,5%
Total
25
12
2i
40
27,6%
increased:
remai-
ning in
the
range of
normals
8
3
0
0
11
7,6%
above
the
upper
limit
of
normals
5
5
0
1
11
7,6%
decreased:
remai^
rung in
the
range of
normals
•
12
4
2
0
18
12,4%
below
the
lower
limit
of
normals
0
0
0
0
0
0,0%
These last cases, as well as the infants in whom the
lysozyme activity in the second investigation did not
return to reference values must be discussed separately.
In the majority of these cases (52 out of 71) the ex-
acerbations of clinical symptoms were observed in the
course of the disease, despite the continued treatment.
In 16 of these 71 infants, already discharged from the
hospital as healthy, the recidive of diarrhoea was ob-
served.
In 25 cases of this group we later found disturbances of
intestinal absorption, digestion and excretion with
following laboratory tests: D-xylose, lactose and glucose
loading tests and the estimation in feces of serum protein,
neutral fat, fatty acids, and soaps.
In two infants with "light diarrhoea" who died from
inborn heart defects, no pathological changes were
found on autopsy in the small intestine, and the lysozyme
activities in the feces were only slightly elevated. In
three infants who died in the course of "toxic diarrhoea"
the morphological changes in the small intestine wall at
autopsy were very pronounced (ulcerations and in-
flammatory infiltrations) and the lysozyme activities in
feces were very high (820.6 units/g, 1079.9 units/g and
3803.7 units/g.).
Our present observations as well as our results concerning
the sources of lysozyme in the gastric wall published
earlier (25) justify the conclusion that the main source
of normal and pathological elevated activities of lysozyme
in the feces are the cellular elements of intestinal wall
especially the neutrophilic granulocytes, monocytes
and macrophages present in "physiological" and "path-
ological" infiltrations.
Conclusions
Summarizing the results of our investigations we can
formulate the following conclusions:
1. The estimation of lysozyme activity in the feces of
infants with acute diarrhoea gives in about 80% of '
cases elevated results which are generally related to
the clinical severity of the disease.
2. The elevated lysozyme activities in the feces are
probably connected with pathological changes in the
intestinal wall such as infiltrations and, in severe cases
even ulcerations.
3. The serial estimation of lysozyme activity in the
feces of infants with acute diarrhoea seems to have
some prognostic value.
4. The estimation of lysozyme activity in feees with the
use of the simple and economic lysoplate diffusion
method should find wide practical application.
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